StonvexLoading…
StonvexStonvexStonvexCore line items from BR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $6.89B | $6.51B | $6.06B | $5.71B |
Operating Income | $1.19B | $1.02B | $936.40M | $759.90M |
Net Income | $839.50M | $698.10M | $630.60M | $539.10M |
EPS (Diluted) | $7.10 | $5.86 | $5.30 | $4.55 |
Total Assets | $8.54B | $8.24B | $8.23B | $8.17B |
Total Liabilities | $5.89B | $6.07B | $5.99B | $6.25B |
Cash & Equivalents | $561.50M | $304.40M | $252.30M | $224.70M |
Free Cash Flow OCF − CapEx | $1.13B | $998.80M | $784.90M | $414.50M |
Shares Outstanding | 117.10M | 116.70M | 118.10M | 117.30M |